Sartorius Aktiengesellschaft (ETR:SRT)
Germany
· Delayed Price · Currency is EUR 167.00
+1.60 (0.97%)
Jun 6, 2025, 5:35 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| Bioprocess Solutions | 2.76B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Bioprocess Solutions Growth | 4.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Lab Products & Services | 683.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Lab Products & Services Growth | 0.18% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBITDA by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| Bioprocess Solutions Underlying EBITDA | 820.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Bioprocess Solutions Underlying EBITDA Growth | 8.15% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Lab Products & Services Underlying EBITDA | 153.90M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Lab Products & Services Underlying EBITDA Growth | -7.84% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2012 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2012 - 2020 |
| EMEA | 1.41B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA Growth | 8.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas | 1.23B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas Growth | -1.15% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific | 800.20M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Pacific Growth | 4.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2011 - 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2011 - 2019 |
| Bioprocess Solutions Order Intake |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Bioprocess Solutions Order Intake Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Lab Products & Services Order Intake |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Lab Products & Services Order Intake Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Order Intake |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Order Intake Growth |
Log In |
Log In |
Log In |
Log In | Upgrade
|